Which  ||| S:0 E:6 ||| WDT
benefits  ||| S:6 E:15 ||| NNS
for  ||| S:15 E:19 ||| IN
the  ||| S:19 E:23 ||| DT
clinician  ||| S:23 E:33 ||| NN
to  ||| S:33 E:36 ||| TO
implement  ||| S:36 E:46 ||| VB
MALDI-TOF ||| S:46 E:55 ||| JJ
/ ||| S:55 E:56 ||| NNP
MS  ||| S:56 E:59 ||| NNP
in  ||| S:59 E:62 ||| IN
the  ||| S:62 E:66 ||| DT
bacteriology  ||| S:66 E:79 ||| JJ
laboratory ||| S:79 E:89 ||| NN
?  ||| S:89 E:91 ||| .
Mass  ||| S:91 E:96 ||| NNP
spectrometry  ||| S:96 E:109 ||| NNS
( ||| S:109 E:110 ||| -LRB-
MALDI-TOF ||| S:110 E:119 ||| NNP
/ ||| S:119 E:120 ||| NNP
MS ||| S:120 E:122 ||| NNP
)  ||| S:122 E:124 ||| -RRB-
is  ||| S:124 E:127 ||| VBZ
a  ||| S:127 E:129 ||| DT
recent  ||| S:129 E:136 ||| JJ
technology  ||| S:136 E:147 ||| NN
especially  ||| S:147 E:158 ||| RB
adapted  ||| S:158 E:166 ||| VBN
to  ||| S:166 E:169 ||| TO
identify  ||| S:169 E:178 ||| VB
microbial  ||| S:178 E:188 ||| JJ
pathogens ||| S:188 E:197 ||| NN
.  ||| S:197 E:199 ||| .
It  ||| S:199 E:202 ||| PRP
has  ||| S:202 E:206 ||| VBZ
rapidly  ||| S:206 E:214 ||| RB
established  ||| S:214 E:226 ||| VBN
itself  ||| S:226 E:233 ||| PRP
as  ||| S:233 E:236 ||| IN
a  ||| S:236 E:238 ||| DT
must  ||| S:238 E:243 ||| NN
for  ||| S:243 E:247 ||| IN
most  ||| S:247 E:252 ||| RBS
medical  ||| S:252 E:260 ||| JJ
bacteriology  ||| S:260 E:273 ||| JJ
laboratories ||| S:273 E:285 ||| NNS
.  ||| S:285 E:287 ||| .
Its  ||| S:287 E:291 ||| PRP$
ease  ||| S:291 E:296 ||| NN
of  ||| S:296 E:299 ||| IN
use  ||| S:299 E:303 ||| NN
and  ||| S:303 E:307 ||| CC
speed  ||| S:307 E:313 ||| NN
of  ||| S:313 E:316 ||| IN
execution  ||| S:316 E:326 ||| NN
typically  ||| S:326 E:336 ||| RB
permit  ||| S:336 E:343 ||| VB
providing  ||| S:343 E:353 ||| VBG
pathogen  ||| S:353 E:362 ||| JJ
identification  ||| S:362 E:377 ||| NN
one  ||| S:377 E:381 ||| CD
day  ||| S:381 E:385 ||| NN
earlier  ||| S:385 E:393 ||| RBR
to  ||| S:393 E:396 ||| TO
the  ||| S:396 E:400 ||| DT
clinicians ||| S:400 E:410 ||| NN
.  ||| S:410 E:412 ||| .
MALDI-TOF ||| S:412 E:421 ||| NNP
/ ||| S:421 E:422 ||| NNP
MS  ||| S:422 E:425 ||| NNP
facilitates  ||| S:425 E:437 ||| JJ
identification  ||| S:437 E:452 ||| NN
of  ||| S:452 E:455 ||| IN
filamentous  ||| S:455 E:467 ||| JJ
fungi  ||| S:467 E:473 ||| NNS
and  ||| S:473 E:477 ||| CC
mycobacteria  ||| S:477 E:490 ||| NNS
that  ||| S:490 E:495 ||| WDT
require  ||| S:495 E:503 ||| VBP
particular  ||| S:503 E:514 ||| JJ
lab  ||| S:514 E:518 ||| NN
expertise  ||| S:518 E:528 ||| NN
when  ||| S:528 E:533 ||| WRB
using  ||| S:533 E:539 ||| VBG
conventional  ||| S:539 E:552 ||| JJ
methods ||| S:552 E:559 ||| NNS
.  ||| S:559 E:561 ||| .
This  ||| S:561 E:566 ||| DT
paper  ||| S:566 E:572 ||| NN
highlights  ||| S:572 E:583 ||| VBZ
the  ||| S:583 E:587 ||| DT
multiple  ||| S:587 E:596 ||| JJ
advantages  ||| S:596 E:607 ||| NNS
that  ||| S:607 E:612 ||| IN
MALDI-TOF ||| S:612 E:621 ||| NNP
/ ||| S:621 E:622 ||| NNP
MS  ||| S:622 E:625 ||| NNP
can  ||| S:625 E:629 ||| MD
bring  ||| S:629 E:635 ||| VB
to  ||| S:635 E:638 ||| TO
the  ||| S:638 E:642 ||| DT
physicians  ||| S:642 E:653 ||| NNS
in  ||| S:653 E:656 ||| IN
their  ||| S:656 E:662 ||| PRP$
practice ||| S:662 E:670 ||| NN
.  ||| S:670 E:672 ||| .
